Viscogel develops a unique medical chitosan enabling improved vaccines and drugs
Viscogel AB develops a novel medical chitosan – Viscosan® - and a viscoelastic gel - ViscoGel® - with unique properties enabling development of improved vaccines and drug delivery systems.
Viscosan® is a new type of chitosan with a lower degree of deacetylation and a higher degree of purity than standard chitosan. Viscogel AB has developed a robust manufacturing process to produce this highly purified chitosan.
ViscoGel® is a viscoelastic gel with unique properties enabling use in medical applications such as a vaccine adjuvant with enhanced characteristics or as a drug delivery system.
Viscosan® and ViscoGel® are non-toxic and biodegradable.
Viscogel AB - Gunnar Asplunds Allé 32, Hus D, 171 63 Solna, Sweden - firstname.lastname@example.org
Research and Development - Viscosan & ViscoGel, medical chitosans for a new class of adjuvants and vaccine carriers.